$30.65
-1.71-5.28%
Last update: Nov 5, 4:00 PM
IDEAYA Biosciences Inc
IDYANASDAQ
The average analyst price target for IDEAYA Biosciences is $51.36, 67.6% above the current price. Of 21 analysts, 19 rate it Buy and 2 Hold. Targets range from $27 to $79. The latest change came on Nov 5, 2026, when Citigroup raised its price target on IDEAYA Biosciences from $65 to $66 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 21 Analysts
Rating Trend — Last 9 Months
